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ABSTRACT
The mercury coordination chemistry of the cyclic dipeptides cyclo(L-alanyl-L- 
histidyl) (cAH), cyclo(L-histidyl-L-histidyl) (cHH), cyclo(L-alanyl-L-methionyl) (cAM), 
and cylco(L-methionyl-L-methionyl) (cMM) was investigated by proton NMR. 
Comparisons were made between the studies of cyclo(L-histidyl-L-histidyl) and cyclo(L- 
alanyl-L-histidyl), as well as between the cyclo(L-methionyl-L-methionyl) and cyclo(L- 
alanyl-L-methionyl) studies. Trends in chemical shift as a function of the metal-to- 
dipeptide ratio were examined, and analysis of the Hg(II):cAM and Hg(II):cMM titration 
studies suggest the possibility of sulfur-mercury(II) interaction. The 8 nitrogen of the 
histidyl side chain was tentatively established as the primary coordination site for Hg(II) 
from analysis of the titration studies of Hg(II):cAH and Hg(II):cHH. Cadmium(II):cHH 
titration studies suggest the possible formation of a 1:2 Cd(II):cHH complex. Also, 
cyclo(L-leucyl-D-prolyl) was synthesized for future solid state NMR evaluation of 
molecular motion in the pure form and as an inclusion complex of a cyclodextrin. 
Cyclo(L-leucyl-D-prolyl) was also fragmented using mass spectrometry and linear 
intermediates of this dipeptide were prepared for future analysis by mass spectrometry.
Characterization of Cyclic and Linear Dipeptides
INTRODUCTION
Imagining a cellular world without proteins is a very difficult, if  not impossible, 
task. Enzyme catalysis dictates physiological conditions in every cell. Furthermore, 
proteins give cells structural support and regulate gene expression. Proteins transport 
energy during photosynthesis and provide defense against foreign invasion. Even more 
remarkable is that proteins can perform all these functions with different numbers and 
sequences of only 20 amino acids.
Over 30 years ago, Anfmsen and his colleagues proposed that the linear sequence 
of amino acids determines the final three-dimensional folded structure of a protein.1 The 
three-dimensional shape of the native protein is what is required for proteins to achieve 
complete biological activity. Errors within the native protein structure or problems with 
the protein folding mechanisms within the cellular environment are the basis for 
numerous human diseases. There are several types of interactions that help to properly 
stabilize the native structure of a protein so that proper folding occurs. These stabilizing 
elements include interactions between amino acids within the same protein chain and 
amino acids on different protein chains, as well as hydrophobic and hydrophilic 
interactions with the surrounding environment. Protein structure can also be stabilized by 
interactions between amino acid cofactors, like metal ions. While there have been many 
recent developments and advances in the characterization of proteins by mass 
spectrometry, X-ray diffraction, and multinuclear NMR techniques, our understanding of 
the folding process is still very limited.
2
3Tandem mass spectrometry is a technique that can be used to determine a 
protein’s fragmentation pattern, thereby predicting the strength of bonds within the 
compound. X-ray crystallography is a technique used to obtain detailed structural 
information about the metal binding sites of native proteins. Large, well-ordered crystals 
of the protein are vital to determination of protein structure by this technique. Solution- 
state NMR, on the other hand, does not require well-formed crystals, and enables the 
characterization of metal-ligand interactions in solution, through the study of nuclear 
shielding interactions between the electron clouds of the ligand and metal. Solid-state 
NMR provides an opportunity to monitor characteristics of disordered solids, and relate 
them to physical properties and molecular motion.
Mass Spectrometry
Mass spectrometry is an analytical technique in which analytes are converted to 
gas-phase ions, which are subsequently separated by their mass-to-charge ratio. The 
resulting display of ion abundance vs. mass-to-charge ratio is the mass spectrum of the 
analyte.3 Early mass spectrometers were based on the deflection of ions moving in a 
magnetic field.4 The sample was introduced, as a vapor, into a vacuum chamber where 
positive ions were formed by electron bombardment. Negatively charged plates at one 
end of the chamber then accelerated the parent ions and product ions resulting from 
subsequent fragmentation through the magnetic field 4 The degree of deflection in the 
magnetic field was based on the ion’s mass, velocity, and charge, and the amount of 
deflection was inversely proportional to each fragment’s mass. Ions of interest were
detected in an ion collector, where an electronic signal was generated and amplified prior 
to recording the results as a function of mass-to-charge ratio.4
This technique proved unsuitable for protein analysis primarily because proteins 
are non-volatile compounds and denature when heated. The recently developed 
techniques of electrospray ionization (ESI) and matrix-assisted laser desorption 
ionization (MALDI), however, have permitted researchers to analyze proteins and other 
large biomolecules.5 In an ESI experiment, the pH of a solution is varied to form ions in 
solution, which are transferred to the gas phase via electric potential.5 In contrast, 
MALDI experiments use lasers to ionize some organic matrix, in which the analytes of 
interest are dissolved.5 These two ion sources have allowed both single stage and tandem 
mass spectrometry experiments to be performed on biomolecules.
Tandem mass spectrometry (MS/MS) is a technique that was developed to 
analyze complex mixtures. MS/MS also provides researchers with the opportunity to 
elucidate the structures o f large molecules, which is virtually impossible with single-stage 
mass spectrometry. MS/MS experiments can be performed with the two stages of mass 
spectrometry (MS-I and MS-II) separated either in space or in time. Separating the two 
stages of mass spectrometry in space involves the use of multiple mass analyzers, such as 
multiple quadrupoles or tandem sectors, which are physically separated. A soft 
ionization source, such as chemical ionization or ESI, is used to produce analyte 
molecular ions with little or no fragment ions. MS-I allows only ions of a particular 
mass-to-charge ratio to pass through its exit slit. The ions then enter a collision chamber, 
usually an rf-only quadrupole, where ions collide with an inert gas, such as argon or 
xenon, to induce further dissociation of the ion.3 This type of fragmentation is called
5collision-induced dissociation (CED). The resulting product ions are then directed into 
MS-II. Since CID produces many characteristic product ions, the identity of the parent 
ion can usually be determined when these product ions are analyzed in the second mass 
spectrometer.
The second MS/MS method involves trapping ions in one place so that multiple 
stages of mass spectrometry can be preformed sequentially in time. Ions accumulate in 
the ion trap and ions with a single mass-to-charge ratio (m/z) of interest are selected. All 
other m/z are removed from the ion trap. The mass-selected ion is then fragmented and 
the product ions are analyzed in a second stage of mass spectrometry in the same 
environment. Both tandem mass spectrometry techniques hold great promise in the 
future characterization of proteins, as they will provide confirmation of peptide sequence, 
as well as providing insight into bond strengths and weaknesses within proteins.
X-ray Crystallography
X-ray crystallography is a useful technique that can determine the detailed 
structure of a protein using a single, well-ordered crystal. Unfortunately, crystallization 
is impeded by the irregular surfaces of proteins. Furthermore, mechanism of metal ion 
incorporation into a protein cannot be determined by X-ray analysis. Nuclear magnetic 
resonance (NMR), however, allows for proteins to be studied in solution and as solids, 
providing a valuable complement to information obtained through X-ray crystallography 
and mass spectrometry.
6Nuclear Magnetic Resonance
NMR is a useful technique for structural characterization because it is potentially 
applicable to all nuclei possessing nuclear spin. Isotopes with suitable spin qualities have 
an odd atomic weight or an odd number of protons and neutrons. A magnetic field is 
created by the spinning motion of charged nuclei. Nuclei with spin 1= Vi are favored in 
NMR experiments as there is a marked reduction in the quality of NMR information 
available for nuclei with spin I > Vi. Two possible spin states arise when the magnetic 
field of a spin Vz nucleus interacts with a magnetic field of greater magnitude. The 
nuclear spin vector may be either aligned with the large magnetic field or against it. 
Alignment with the external magnetic field is more energetically favorable for the 
nucleus and a slight excess of nuclei populate the lower energy spin state in accordance 
with the Boltzman distribution constant.6
NMR spectroscopy involves excitation between available spin states. 
Radioffequency radiation can be used to excite the nuclear spin vector into a higher 
energy level(s), producing a non-equilibrated distribution of spin states. Free induction 
decay (FID), the result of vector relaxation back to equilibrium, produces a series of 
exponentially decaying sine waves, whose amplitudes are plotted as a function of 
frequency. A typical NMR is the result of a Fourier transformation of this data, and is 
particularly useful as not all nuclei of the same type resonate at the same frequency and 
field. A precession frequency of
co= y ( l-a )B o
results from the phenomenon called shielding, where y is equal to the magnetogyric ratio, 
a constant that describes how much magnetism arises from the spin and a  equals the
7shielding paramater. This effect is called chemical shift and varies depending on the 
degree of shielding of a particular nucleus and the specific bonds involved.7
Spin coupling is an important aspect of NMR that provides information about the 
environment of a given nucleus.8 Coupling manifests itself in an NMR spectrum as a 
split peak. Coupling occurs when through-bond connectivity between two nuclei exists.7 
Splitting arises because nuclear spins can be coupled via bonded electrons. The result is 
that the nuclei experience two different microenvironments and thereby each resonates at 
two slightly different frequencies. This frequency difference is equal to the scalar spin 
coupling constant J. The number of types of bonds through which the nuclei are coupled 
determines the magnitude of J. Further, the Karplus relationship
Jxy = A cos 2<() + B cos (j) + C 
where A, B, and C are empirical constants and (|) is the dihedral angle, can be used in 
conjunction with coupling constants to determine dihedral bond angles.7 However, the 
relationship is a causal one, as two different angles can produce the same coupling 
constant.7
High-resolution NMR spectra of quadrupolar nuclei can be obtained from solid- 
state samples. MQ-MAS (multiple quantum magic-angle spinning) is a solid-state NMR 
technique that can be employed using conventional NMR spectrometers and probes. In 
general, solid-state NMR produces much broader, overlapping spectral lines than 
solution-state NMR. The low sensitivity of solid-state NMR also imposes the need to 
signal average multiple spectra to improve the poor signal-to-noise ratios.9 The lower 
signal-to-noise ratio of solid-state NMR compared to solution-state NMR can be 
attributed to the different NMR spectrum of each molecular orientation in a solid
compound, whereas with solution-state NMR these differences are averaged out by 
molecular tumbling. However, MAS can be utilized to overcome the drawbacks of 
spectral broadening and low signal-to-noise ratios as it narrows spectral lines by 
emulating the molecular tumbling observed with solution-state NMR. Employing MAS 
involves spinning samples in a rotor with an axis of 54.74° with respect to the magnetic 
field. A cubically symmetrical motion, which is imposed by the trajectory, is an adequate 
approximation to spherically symmetric motion that spectral broadening is averaged 
away and relatively sharp NMR resonances are obtained.9
Metal Ion Coordination to Proteins
The ideal heteronuclear NMR probe possesses spin I = Vi nuclei, which have 
narrow resonance ranges, thereby permitting the detection of heteronuclear coupling. 
Abundant nuclei associated with a wide chemical shift range and large coupling constants
1 1 1
are most useful in NMR studies. Biologically relevant spin I = Vi nuclei include H, C, 
15N, and 113Cd. The natural abundance of these nuclei ranges from 1.1% (13C) to 99.9% 
(!H). The chemical shift ranges of these nuclei also vary. Proton NMR is frequently used 
to characterize proteins, unfortunately the limited chemical shift range of this nucleus
1 1  I  ^
leads to considerable spectral overlap. C and N are also somewhat unfavorable, as 
they are both o f low natural abundance. Fortunately, many proteins incorporate metal 
ions into their active sights and NMR characterization of these metal-binding sites may 
provide valuable information. Unfortunately, none of the physiologically relevant metals 
(e.g. copper, zinc, iron and magnesium) have isotopes with favorable NMR properties. In
9some cases, however, it is possible to substitute metals possessing favorable NMR 
properties for native metal ions and obtain relevant spectroscopic information.
199Hg(II) is one metal ion that possesses favorable NMR characteristics. This ion 
has a chemical shift range of more than 3000 parts per million.10 199Hg is the only spin I 
= lA isotope of mercury. It has a natural abundance of 16.8% and large coupling 
constants.10 In addition, it has a receptivity 5.4 times greater than 13C and its chemical 
shift is very sensitive to the number and identity of bound nuclei.11 Mercury NMR may 
thus prove to be a valuable technique for elucidating aspects of metalloprotein structure 
and folding.
Mercury is known to form complexes with nitrogen, sulfur and phosphorous with 
stability rarely exceeded by any other divalent cation. When compared to several 
physiologically essential transition elements, mercury exhibits similar charge and 
coordination geometry preferences. Metal binding studies have shown competition
1 j
between mercury, zinc and copper for protein binding. In several instances, 
metalloenzymes with mercury in place of the normal metal have retained catalytic 
activity.10 Several mercury-substituted proteins have been characterized by recently 
developed multinuclear NMR techniques demonstrating preservation of protein
1 'K *structure. However, an understanding of how and why proteins fold still eludes 
researchers.
Greater knowledge of protein folding processes will ultimately contribute to a 
better understanding of biological systems, as proteins are important in all of the 
metabolic pathways of living organisms. Studies of metal binding to peptides will also 
assist in the understanding of metal binding by proteins, which is important because
10
metal ion transport in body fluids and through membranes is strongly dependent on the 
relative complexing ability of amino acids and their peptides. A better understanding of 
the mechanism of protein folding itself may provide effective therapies for diseases 
caused by altered protein folding, such as Alzheimer’s and scrapie.2
Three-dimensional folding of a polypeptide is, however, a very complex process. 
Proteins are synthesized by sequential addition of amino acids onto a linear chain. Since 
the folded structure brings amino acids far apart on the chain close together, the exposed 
end of the growing protein chain must remain at least partially unfolded until amino acid 
assembly is completed. Furthermore, proteins must fold in a heterogeneous aqueous 
solution, which provides numerous opportunities for folding/misassociation errors. Cells 
have evolved mechanisms, like molecular chaperones, which are responsible for 
preventing misassociations and facilitating proper folding under optimal cell conditions. 
In addition, some proteins require association with ions or small molecules to perform 
their catalytic function. There is some evidence that these cofactors may sometimes 
participate in the folding process.12
E D C
A— B C  D E F G  H 1  ►  F A----- B
G H 1
Figure 1: Simplistic model of protein folding.
Most protein folding studies have focused on the unimolecular process for 
proteins containing a single amino acid chain and no cofactors. Much simpler model 
studies are necessary to develop new tools for investigation of the more complex
11
bimolecular process involved in folding a metalloprotein. Through the detection of 
heteronuclear 'H-metal coupling, previous protein metal binding site model studies have 
demonstrated Hg(II) binding in solution with both tridentate and tetradentate ligands, but 
not lower coordinate ligands. Both tetradentate and tridentate ligands have limited 
degrees of freedom and provide a claw-like feature in binding, thus the development of 
an even simpler protein model with similar features would be ideal for future protein 
folding studies.
Cyclic dipeptides possess a diketopiperazine ring system which restricts the 
degrees of freedom of metal coordinating amino acid side chains. When the 
diketopiperzine ring is in the “boat conformation”, the amino acid side chains are 
oriented for pincher-like metal coordination. Cyclic dipeptides can thus be used to mimic
Figure 2: The metal induced cyclic dipeptide "folding" process. R is a metal binding group.
the close proximity of two amino acid side chains bound to a metal ion in a protein active 
site. Furthermore, cyclic dipeptides provide an alternative to studying entire proteins by 
reducing the high variability associated with linear peptide chains and by achieving
12
greater structural simplicity for characterization by X-ray diffraction, solution-state NMR 
studies, solid-state NMR studies, mass spectrometry*, and circular dichroism.
Many functional groups in proteins and peptides are potential metal coordination 
sites, as demonstrated in studies of metal binding with simple amino acids and other 
compounds. Histidine, for example, is a substantial contributors to protein structure and 
function and an essential amino acids in infants.14 Histidine residues bind heme 
prosthetic groups in hemeglobin.14 Methionine is another biologically important residue 
often encountered in the metal binding sites of proteins. Methionine is also an 
appropriate component for metal-bound ligands in mercury coordination studies because 
mercury forms a stable Hg-S bond to sulfur containing amino acid residues, resulting in 
“tight binding” to proteins in living systems.15 Investigating methionine and histidine 
interactions with mercury (II) will thus provide valuable insight that will aid in further 
understanding protein-metal interactions.
Past Studies
Metal Ion/Amino Acid Interactions
To date, there are few detailed studies of metal ion interactions, excluding 
terminal functional group effects, with side chain substituents and an amide linkage. In 
one existing study, four criteria were used to create model ligands for characterizing 
Cu(II) interactions with protein side chains and amide linkages.16 First, terminal carboxyl 
or amine groups were excluded from model ligands, except specifically as a side chain
* Uncoordinated cyclic dipeptides will be characterized with mass spectrometry, whereas both 
uncoordinated and metal-coordinated cyclic dipeptides will be studied by X-ray diffraction, solution-state 
NMR, solid-state NMR, and circular dichroism.
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function. Second, model ligands were required to possess an amide linkage a  to the 
substituted carbon of any amino acid residue. Third, the model ligands had to be easily 
prepared from a variety of natural and synthetic amino acids. Finally, the model ligands 
were kept sterically simple, but amenable to synthetic modification. These guidelines are 
applicable to cyclic dipeptides proposed for 199Hg NMR studies.16
199Hg NMR Studies o f  Mercury (II) Substituted Metalloproteins
The mercury ion has chemical characteristics suitable for 199Hg and ]H NMR 
investigation of the structure and function of biopolymers. Mercury (II) preserves 
catalytic activity when substituted for native metal ions of several metalloenzymes.15 
Mercury also adopts the coordination environments of native metals as determined by a 
combination of 199Hg NMR techniques, when substituted into a variety of Fe, Cu and Zn 
metalloproteins.17 199Hg NMR provided insight into allostery of MerR-DNA 
interactions.17 The MerR protein activates transcription of genes responsible for mercury 
detoxification after changes in intracellular metal ion concentration are detected. The 
conformation of MerR, and its biological activity as a transcription activator, are Hg(II) 
dependent.
Previous NMR and circular dichroism (CD) studies characterizing tetrapeptides 
have also been used to establish the biological significance of chelated proteins. 
Tetrapeptide fragments Cys-X-Y-Cys (X,Y = amino acid residues) are found in the metal 
binding sites of many metal thiolato proteins.18 These proteins include C. pasteurianum 
rubredoxin, Spirulina plaensis ferredoxin, E. coli aspartate carbamoyl transferase, and 
renal metallothionem. Spectroscopic characterizations of Fe4 S4  complexes of cys- 
containing tetrapeptides were determined using !H NMR and CD in a study of
14
* 1 8 * 1  electrochemical properties of the chelating tetrapeptide complexes. In this study, H
NMR was used to establish the chelation of Cys-X-Y-Cys to the [4Fe-4S] cluster by the
observation of two sets of characteristic NMR signals of CysCpF^.18 Two peaks
around 12-14 ppm (in Me2 SO-d6  or dichloromethane-d2 ) were observed in [4Fe-4S]
complexes of tripeptides and dipeptides containing a cysteine residue. These peaks were
the result o f non-equivalent CpH2 protons that were contact-shifted by the Fe4 S4 2+ core
through the C-S-Fe bond . 18
The solvent dependence of lH NMR and CD spectra of [Fe4 S4 (Z-Cys-Gly-Ala-
CysOMe)2 ] ' were interpreted as demonstrating flexible chelation of the peptide. Circular
dichroism results supported chelating coordination of two cysteine-containing peptides to
• 1 8  • * a single cluster. This experiment established that the invariant sequence around Fe4 S4
in bacterial ferredoxins might play an important role in electron transfer, especially in
influencing the direction of flow of electrons in biological electron-transfer chains.18
Cyclic Dipeptide or Protein Folding Secondary to Metal Ion Binding
Cyclic diglycine, the simplest cyclic dipeptide, exists in a planar ring 
conformation. Replacement of one or both of the glycines by an amino acid with a larger 
group changes the preferred conformation. When an aryl substituent was used in studies 
of 2,5-dioxopiperazine’s (DOP’s), three conformations of the DOP ring were observed: 
planar (Figure 3), flagpole boat (Figure 4), and bowspirit boat (Figure 5). 19 Initially 
reported as responsible for the ring-shielding effects observed in NMR spectra, the 
flagpole conformation appears to be the most common for cyclic dipeptides with two 
aromatic sidechains, possibly as a result of attractive forces between the two rings. This
15
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Figure 3: Planar 
conformation o f DOP ring
Figure 4: Flagpole boat 
conformation o f DOP ring
Figure 5: Bowspirit boat 
conformation o f DOP ring
conformation is apparently less favored for non-aromatic substituents.19 In limited 
previous studies of metal binding by cyclic dipeptides, metal binding induced the 
flagpole conformation.19
The “folding” process to be investigated involves the cyclic dipeptide ring flip 
from the bowspirit structure, with the side chains pointing out, to the flagpole structure 
with the side chains both directed at a metal. Cyclic dipeptides with two metal binding 
groups, for example cyclo(L-histidyl-L-histidyl) and cyclo(L-methionyl-L-methionyl), 
will be compared to those with just one metal binding group. The side chains of the 
amino acids histidine (Figure 6) and methionine (Figure 7) are frequently bound to metals 
in proteins, while the side chain of alanine (Figure 8) is incapable of metal binding. 
Cyclo(L-histidyl-L-histidyl) (Figure 9) and cyclo(L-methionyl-L-methionyl) (Figure 10)
HC
H2 II 
-c— c
\
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CH
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Figure 6: Histidine side chain Figure 7: Methionine side chain Figure 8: Alanine side chain
o  
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Figure 9: Cyclo(L-methionyl-L-methionyl) Figure 10: Cyclo(L-histidyl-L-histidyl)
are available in one step synthesis from commercially protected amino acids. Protected 
dipeptides containing two different amino acids were synthesized as precursors to 
cyclo(L-alanyl-L-methionyl) (Figure 11) and cyclo(L-alanyl-L-histidyl) (Figure 12).
NH NH
HN
O
NH
HN
O
Figure 11: Cyclo(L-alanyl-L-methionyl) Figure 12: Cyclo(L-alanyl-L-histidyl)
Cyclic dipeptides will also be studied through solid-state NMR, in their solid, 
crystalline form and as guests in the hydrophobic cavities of cyclodextrin inclusion 
compounds. Controlling the host-guest intermolecular potential can be achieved by 
confining dipeptides in cyclodextrins of progressively larger cavity sizes. Successful 
inclusion of the cyclic dipeptide into a cyclodextrin will alter the ligand environment
17
thereby changing its dynamics, and thus changing the solid state NMR characterization of 
the dipeptide. The cyclic dipeptide cyclo(L-leucyl-D-prolyl) was chosen for use in this 
study because it has been previously characterized by X-ray crystallography and is 
biologically active. (3 cyclodextrin will be used to host the cyclo(L-leucyl-D-prolyl) 
(Figure 13) in a 1:2 ratio of guest:host. This study will also serve to complement related 
studies of leucine and cyclo(L-leucyl-L-glycyl).
o
HN
o
Figure 13: Cyclo(L-leucyl-D-prolyl)
EXPERIMENTAL
Unless otherwise noted all of the reagents and solvents used were commercially 
available. All syntheses were performed under argon, except for X-ray crystal growth, 
and organic products and crystals were purged with argon for storage. NMR was used 
to check the purity of all intermediates. The purity of ligands was confirmed using !H
1 TNMR and C NMR spectroscopy. A Melt-Temp® melting point apparatus was used to 
obtain all melting points. Nuclear Magnetic Resonance Spectroscopy was performed on 
all samples using a Varian Mercury 400 MHz spectrometer and all chemical shifts are 
reported relative to tetramethylsilane. Elemental Analysis was preformed by Atlantic 
Microlabs, Inc. A. Deer and J. Poutsma performed all mass spectrometry experiments.
Synthesis of N-(Benzyloxycarbonyl)-L-Alanyl-L-Histidyl Methyl Ester (ZAHOMe)
Both the N-benzyloxycarbonyl protected dipeptide and the cyclic dipeptide were 
prepared by modification of literature procedures.20,21 A solution of N- 
(benzyloxycarbonyl)-L-alanine (Z-AlaOH; 12.00 g, 8.95 mmol) in 50 mL of acetonitirile 
was prepared with stirring under argon. Dicyclohexylcarbodiimide (DCC; 1.84 g, 8.95 
mmol) and then 4-nitrophenol (1.25 g, 8.95 mmol) were added to the Z-AlaOH solution. 
After stirring for approximately one hour, the precipitated DCU (dicyclohexylurea) was 
removed by vacuum filtration. The filtrate was added to a solution of L-histidine methyl 
ester (L-HisOMe; 2.17 g, 8.95 mmol) dissolved in acetonitrile (50 mL) and triethylamine
18
19
(2.45 mL, 17.90 mmol) that had been stirring for 5.5 hours. This reaction mixture was 
stirred under argon for 2 days.
Crude ZAHOMe was removed from solution via vacuum filtration and rinsed four 
times with 10 mL portions of acetonitrile, until the solid was no longer yellow, and then 
rinsed once with 20 mL of diethyl ether. The sample was sequentially suspended in 30 
mL of chloroform, 30 mL of 0.5 M aqueous ammonia, and 30 mL of deionized water, 
with vacuum filtration between washings. The white solid was recrystallized from 
ethanol/ether. Crystals were isolated via vacuum filtration and then thoroughly dried 
under vacuum overnight, yielding 1.08 g of white ZAHOMe crystals. MP: NMR:
(DMSO-d6) (Appendix 1): 6 8.31 (d, J =  8.2 Hz, Hc), 7.53 (s, Hi), 7.49 (d, J =  9.3 Hz, 
Hf), 7.36 (m, HaHa>,Ha”), 6.83 (s, Hj), 5.02 (dd, J=  12.9, 4.6 Hz, Hb), 4.47 (q, J = 7.2 Hz, 
Hg), 4.08 (p, J=  7.3, 8 Hz, Hd), 3.57 (s, Hi), 2.38 (m, Hh), 1.20 (d, J=  8.5 Hz, He)
Synthesis of Cyclo(L-Alanyl-L-Histidyl) (cAH)
To remove the Z protecting group, ZAHOMe (1.08 g, 2.87 mmol) was 
hydrogenated (40 psi, H 2 ) with 10% palladium-carbon catalyst (0.107 g) in 50 mL of 
methanol for 6.5 hours. The methanol solution was vacuum filtered through a celite bed. 
The filtrate was refluxed under argon for 60 hours and the solvent was removed by rotary 
evaporation to produce a white solid. Cyclo-(L-alanyl-L-histidyl) was then recrystallized 
from methanol and dried under vacuum overnight producing 0.4866 g (2.34 mmol) of 
white cAH crystals (81% yield). MP: 244-247°C ’H NMR: (DMSO-d6) (Appendix 2): 
S 8.19 (s, Hc), 8.10 (s, Hf), 7.98 (s, HO, 7.56 (s, Hb), 6.81 (s, Ha), 4.05 ( t,/ =  6.8 Hz , Hh), 
3.81 (q, J =  6.9 Hz, He), 2.97 (dd, J=  3.4, 11.2 Hz, Hd), 2.86 (dd, J =  6.0, 8.6 Hz, Hd.),
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0.97 (d, J =  6 . 8  Hz, Hg) 13C NMR: (DMSO-d6) (Appendix 4): 6  169.04, 167.73, 135.38, 
133.41, 118.06, 55.35, 50.49, 30.69, 19.64 Elemental Analysis: Calculated for
(C9 Hi2 N 4 0 2 )4 *CH3 0 H: C, 51.38; H, 6.06; N, 25.91; O, 16.65 Found: C, 51.35; H, 5.81
Synthesis of Cyclo-(L-Histidyl-L-Histidyl) (cHH)
Cyclo(L-histidyl-L-histidyl) was prepared with modification of the literature 
procedure used by Abdehalden and associates . 2 2  L-Histidine methyl ester dihydrochloride 
(5.00 g, 20.65 mmol) was dissolved in 100 mL of hot methanol and allowed to cool to 
room temperature. Sodium methoxide (4.99 mL of 30 wt % NaOCHs/CHsOH) was 
added to the room temperature solution. One minute later, 50 mL of diethyl ether was 
added. After approximately two minutes the NaCl that formed was removed via vacuum 
filtration. The filtrate was reduced to dryness via rotary evaporation. The residue was 
stirred in a 37°C oil bath for 8  days under argon. A white solid was removed from the 
solution by means of vacuum filtration, and washed with several 20 mL portions of cold 
methanol. Cyclo(L-histidyl-L-histidyl) was isolated by recrystallization from ultra pure 
deionized hot water. The cHH was further dried overnight in a vacuum oven at 100°C, 
yielding 355 mg of a white solid (12.5 % yield). MP: 269-278°C (dec) 'H NMR: 
(DMSO-ds) (Appendix 3a): 8  7.98 (s, Hc), 7.58 (s, Hb), 6.78 (s, Ha), 3.98 (t, J  = 4.1 Hz, 
He), 2.99(dd, J =  4.0, 15.0 Hz, Hd.), 2.58 (d d ,/=  8.9, 6.4 Hz, Hd) 13C NMR: (DMSO- 
df,) (Appendix 3b): 5 167.61, 135.53, 134.02,117.96, 55.22, 31.03
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Synthesis of N-(Benzyloxycarbonyl)-L-Alanyl-L-Methionyl Methyl Ester 
(ZAMOMe)
ZAMOMe and cAM were both prepared with modifcation to literature 
procedure . 2 3  N-(Benzyloxycarbonyl)-L-alanine (Z-AlaOH; 5.00 g, 22.39 mmol) was 
dissolved in approximately 100 mL of still dried tetrahydrofuran and cooled to -10°C in 
an ice/salt bath. N-methylmorpholine was added (2.46 mL, 22.39 mmol) to the cooled 
solution. L-Methionine methyl ester hydrochloride (L-MetOMe; 4.47lg, 22.39 mmol) 
was suspended in approximately 50 mL of N,N-dimethylformamide (DMF). The DMF 
suspension was heated slightly to ensure saturation and cooled to room temperature. 
Isobutyl chloroformate (2.904 mL, 22.39 mmol) was added to the Z-AlaOH solution 
under a light stream of argon. In the next minute, triethylamine (3.06 mL, 22.39 mmol) 
was added to the cooled N,N-dimethylformamide solution. This N,N- 
dimethylformamide mixture was added to the tetrahydrofuran solution described above. 
This solution was stirred under argon for three days. Salts were removed by vacuum 
filtration, rinsing with tetrahydrofuran (THF) and the THF was removed via rotary 
evaporation. Ultra pure water (20mL) was added and the solution was extracted with 
methylene chloride (3 x 30 mL). The combined organics were dried with sodium sulfate 
and the solution was reduced via rotary evaporation to a colorless oil. Ultra pure water 
(100 mL) was added to the residue. Following two days of refridgeration, white N- 
(Benzyloxycarbonyl)-L-alanyl-L-methionyl methyl ester (ZAMOMe) crystals were 
removed via vacuum filtration and dried under vacuum overnight yielding 5.15 g (15.32 
mmol) of ZAMOMe (68.4% yield). 'H  NMR: (DMSO-d6) (Appendix 4): 8  8.24 (d, J  =
11.6 Hz, Hc), 7.41 (d, / =  7.7 Hz, Hf), 7.34 (m, Ha> Ha., Ha"), 4.99 (s, 2 Hb), 4.39 (q, J  =
22
7.5, 8.9 Hz, Hg), 4.07 (p, J =  7.5, 6 . 8  Hz, Hd), 3.62 (s, 3 Hk), 2.44 (m, Hi), 2.03 (s, 3 Hj), 
1.99 (m ,H h), 1.20 (d, .7=7.7 Hz, He)
Synthesis of Cyclo(L-Alanyl-L-Methionyl) (cAM)
ZAMOMe (5.15 g, 15.32 mmol) was hydrogenated (40 psi, H2 ) with 10% 
palladium-carbon catalyst (0.0575 g) in 100 mL of methanol for 18 hours. This solution 
was vacuum filtered through celite and the filtrate volume was reduced by rotary 
evaporation to produce a thick yellow oil. Crude L-alanyl-L-methionyl methyl ester 
(AMOMe) oil was refluxed with -140 mL of toluene for 24 hours. Toluene was removed 
through rotary evaporation, and the resulting translucent yellow cAM crystals were dried 
under vacuum for ~18 hours, producing 3.46 g of crude cAM (78% crude yield). 
Cyclo(L-alanyl-L-methionyl) was recrystallized in 350 mL of ethyl acetate. The 
resulting crystals were vacuum filtered and dried overnight under vacuum, yielding 
6 .6 8 % cAM (0.2314 g). Attempts to retrieve more cAM from the mother liquor were 
unsuccessful. Mp: 220-224°C 'H NMR: (DMSO-d6) (Appendix 5a): 8  8.15 (d, J =  8  
Hz, 2 He), 3.93 (t, J  = 5.1 Hz, Hd), 3.88 (q, J =  6.9 Hz, Hg), 2.58 (m, Hb), 2.01 (s, Ha), 
1.94 (m, Hc), 1.24 (d, J =  6.9 Hz, Hf) 13C NMR: (DMSO-d6) (Appendix 5b): 8  169.65, 
168.29, 53.80, 50.51, 32.78, 29.49, 19.81, 15.26 Elemental Analysis: Calculated for 
C8H 14N 2 O2 S: C, 47.52; H, 6.93; N, 13.86. Found: C, 47.79; H, 7.00; N, 13.66.
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Synthesis of N-(BenzyIoxycarbonyl)-D-Prolyl-L-LeucyI Methyl Ester (ZPLOMe)
N-(Benzyloxycarbonyl)-D-proline (Z-ProOH; 2.00g, 8.02 mmol) was dissolved in 
~20 mL of still dried THF and then cooled to -10°C, while stirring under argon. N- 
methylmorpholine (0.880mL, 8.02 mmol) was added to the reaction vessel. L-leucine 
methyl ester hydrochloride (1.457g, 8.02 mmol) was dissolved in ~20 mL of N, N- 
dimethylformamide (DMF). Isobutyl chloroformate (1.04 mL, 8.02 mmol) was then 
added to the Z-ProOH solution. In the next minute, triethylamine (1.09 mL, 8.02 mmol) 
was added to the DMF solution. The entire mixture was then added to the Z-ProOH 
reaction vessel and allowed to react for 4 days under argon. The formed salts were 
removed through vacuum filtration. The solvent was removed through rotary evaporation. 
The residue was dissolved in ~40 mL of chloroform and extracted with ultra pure 
deionized water (3 x 30 mL). The organic layer was dried with sodium sulfate, filtered 
and rotary evaporated. Crystallization of the resulting clear, yellow oil was induced by 
the addition of -50  mL of 4°C ultra pure water. The crystals were removed via vacuum 
filtration and dried overnight in vacuo, resulting in 1.419 g (3.7 mmol, 46% yield) of 
ZPLOMe. lH  NMR: (DMSO-d6) (Appendix 6 ): 5 8.02 (s, Hg), 7.03 (m, Ha, H.*, Ha»), 
4.19 (t, J = 7.5 Hz, Hf), 4.00 (t, J = 6.9 Hz, Hh), 3.63 (s, Hb), 2.31 (s, Hi), 2.11 (m, Hi, Hj), 
1.83 (m, Hd), 1.35 (m, Hc), 0.87 (dd, J = 3.5, 3.0 Hz, Hk)
Synthesis of N-(Benzyloxycarbonyl)-L-Leucine (Z-LeuOH)
L-leucine (l.OOg, 7.62 mmol) was suspended in 20 mL o f ultra pure deionized 
water. Two equivalents of triethylamine (2.1 mL, 15.2 mmol) and 10 mL of 95% ethanol 
were added to the L-leucine suspension. Solid N-(benzyloxycarbonyloxy)-succinimide
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(1.89g, 7.62 mmol) was added to the reaction vessel. This mixture was allowed to stir 
under argon for two days. The colorless solution was concentrated by rotary evaporation. 
The residue was diluted with 50 mL of 100% ethanol and concentrated by rotary 
evaporation three times. The residue was then dissolved in 10 mL of chloroform and 
extracted three times with dilute HC1 pH=2. The organics were dried with sodium 
sulfate, filtered, and concentrated through rotary evaporation. The resulting Z-LeuOH oil 
was dried in vacuo, yielding 1.612g (6.00 mmol, 78.7% yield). JH NMR: (DMSO-d6) 
(Appendix 7): 6  12.57 (s, Hh), 7.59 (d, J = 9.2 Hz, Hc), 7.35 (m, Ha, Ha , Ha>), 5.03 (s, Hb), 
3.96 (s, Hd), 1.47 (m, He), 1.45 (m, Hf), 0.85 (dd, J = 6 .8 , 4.9 Hz, Hg)
Synthesis of N-(Benzyloxycarbonyl)-L-Leucyl-D-Prolyl Methyl Ester (ZLPOMe)
Z-LeuOH was dissolved in 75 mL of still dried THF and chilled to -10°C, while 
stirring under argon. N-methylmorpholine (0.598 mL, 6.00 mmol) and isobutyl 
chloroformate (0.778 mL, 6.00 mmol) were added to this mixture. Within one minute of 
adding the isobutyl chloroformate to the reaction vessel, triethylamine (0.826 mL, 6.00 
mmol) was added to D-proline methyl ester hydrochloride (D-ProOMe; 0.776g, 6.00 
mmol) dissolved in 35 mL of room temperature N,N-dimethylformamide (DMF). The 
entire D-ProOMe/ DMF mixture was then added to the reaction vessel and allowed to 
react, under positive argon pressure, for 1 0  days, at which point the resulting salts were 
removed through vacuum filtration. An extraction with ultra pure deionized water of the 
resulting Z-L-leucinyl-D-prolyl methyl ester (ZLPOMe) dissolved in -50  mL of 
chloroform followed and was repeated twice. Excess water was removed with the 
addition of sodium sulfate and the chloroform was removed via rotary evaporation. The
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resulting yellow oil was dried overnight in vacuo yielding 1.9387g (5.15 mmol) of 
ZLPOMe (85.8% yield). ‘H NMR: (DMSO-d6) (Appendix 8 ): 8  7.56 (s, Hc), 7.36 (m, 
Ha,H a.,H a..), 5.03 (s, Hb), 4.36 (t, J = 12.8 Hz, H k), 4.25 (dd, J = 6.9, 8.5 Hz, Hd), 2.73 (s, 
Hi), 2.18 (m, Hh, Hj, Hj), 1.90 (m, He, Hf), 1.53 (m, Hh, H„ Hj), 0.89 (m, Hg)
Synthesis of CycIo(L-Leucyl-D-ProIyl) (cLP)
The N-benzyloxycarbonyl protecting group was removed from the linear 
dipeptides, ZLPOMe and ZPLOMe, via hydrogenation. ZLPOMe (1.9387 g, 5.15 mmol) 
was added to 0.1931 g of palladium over carbon (Pd/C) dissolved in ~50 mL of 
methanol. The mixture was allowed to react with 40 psi of hydrogen gas for 48 hours. 
Pd/C was removed from the mixture by vacuum filtration through celite. The resulting 
filtrate was then reduced to a concentrated oil of L-leucyl-D-prolyl methyl ester 
(LPOMe) via rotary evaporation* and dissolved in 100 mL of toluene. The LPOMe- 
toluene mixture was allowed to reflux for ~24 hours under argon. Toluene was removed 
through rotary evaporation and the remaining solid recrystallized in 50 mL of 
tetrachloroethylene. Off-white crystals were removed via vacuum filtration and dried 
overnight. From ZLPOMe: 26.3% cLP (0.3311 g, 1.577 mmol). Mp: 163-165°C lH 
NMR: (DMSO-d6) (Appendix 9a): 6  7.97 (s, He), 4.17 (t, J =  8  Hz, Hc), 3.98 (t, J =  8  Hz, 
Hd), 2.09 (m Hf), 1.80 (m Hj; h, 0, 1.34 (m Hb), 0.81 (q, J =  4 Hz, Ha). 13C NMR: 
(DMSO-d6) (Appendix 9b): 6  170.99, 167.15, 59.21, 53.33, 45.63, 38.51, 28.21, 24.85, 
23.62, 23.26, 22.68 MS: (H2 0:CH 3 0H , 50:50 v/v) (Appendix 9c): 211, 194, 183, 181, 
167, 155, 153, 138, 127, 8 6 , 70
* Crude hydrogenation products, LPOMe and PLOMe, were also used in mass spectrometric analysis by J. 
Poutsma and A. Deer.
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From ZPLOMe: 28.7 % cLP (0.4078 g, 1.94 mmol) Mp: 158-164°C 'H NMR 
(DMSO-d6) (Appendix 10a): 8  8.02 (s, He), 4.19 (t, J =  8  Hz, Hc), 4.00 (t, J =  8  Hz, Hd), 
2.11 (m, Hf), 1.82 (m, Hg, h, i), 1.34 (m, Hb), 0.86 (q J= 4 Hz, Ha) ,3C NMR: (DMSO-d6) 
(Appendix 10b): 8  171.03, 167.13, 59.21, 53.35, 45.63, 38.55, 28.21, 24.86, 23.62, 
23.27, 22.70 Elemental Analysis: Calculated for CnHi8N2 0 2: C, 62.86; H, 6.57; N, 
13.33. Found: C, 62.40; H, 8.64; N, 13.20.
Attempted cLP Integration into p Cyclodextrin by Slow Evaporation (Method I)
p cyclodextrin (1.94 g, 1.710 mmol) was suspended in 40 mL of ultra pure water. 
180 mg (0.856 mmol) of cLP was added to the suspension and the mixture heated until 
all materials dissolved. The solution was filtered by gravity, to remove impurities and 4 
mL of the resulting filtrate was transferred into each of four 8  mL vials. The vial caps 
were attached loosely enough to allow for evaporation to occur. The remaining filtrate 
was transferred into a 50 mL Erlenmeyer flask and covered with a Kimwipe. The vials 
and Erlenmeyer were allowed to sit, undisturbed for three weeks at which time clear 
crystals were harvested and sent for elemental analysis. MP: 270-275°C Elemental 
Analysis: Calculated for C9 5 H 1 5 8 O7 2 N 2 : C, 46.00; H, 6.42; N, 1.13; O, 46.44. Found: C, 
39.26; H, 6.75; N, 0.00 -  consistent with pCD (C4 2 H7 0 O3 5 -  Calculated: C, 40.44 H, 6.23 
O, 49.34).
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Attempted cLP Integration into p Cyclodextrin by Lyophilization (Method II)
P cyclodextrin (325 mg, 0.286 mmol) was suspended in 5 mL of ultra pure water. 
cLP (30 mg, 0.143 mmol) was added to the suspension and the mixture heated until the 
solution became clear. The solution was gravity filtered into an 200 mL roundbottom 
flask and frozen by rotating the roundbottom in a liquid nitrogen bath. The frozen 
mixture was then placed on a Labonco Freeze-Dry System/Freezone® 4.5 to dry 
overnight, resulting in a white powder, 65% yield (230 mg, 0.0927 mmol). MP: 275- 
285 °C Elemental Analysis: Calculated for C9 5 H 1 5 8 O7 2 N 2 : C, 46.00; H, 6.42; N, 1.13; 
O, 46.44. Found: C, 42.84; H, 6.72; N, 1.07; O, 49.37.
Preparation of NMR solutions for NMR titrations of cMM and Hg(C104)2
A 142 mM stock solution of cMM (0.0746 g, 0.0832 mmol) in DMSO-d6 was 
prepared in a 2 mL volumetric. Separately, a 20 mM stock solution of mercury 
perchlorate (9.07 mg, 0.02 mmol) was prepared in a 1 mL volumetric. Solutions with 
metal-to-ligand ratios of 0.0156, 0.0208, 0.0313, 0.0625, 0.125, 0.25, 0.50, 1.0, 1.25, 
1.50, and 2.0 were prepared from the stock solutions and DMSO-d6 . To prepare each 
metal-to-ligand ratio, 65 pL aliquots of the 20 mM Hg(C1 0 4 )2 -DMS0 -d6  stock solution 
were placed in NMR tubes and diluted with varying amounts of cMM and DMSO-d6  to 
obtain total volumes of 650 pL, yielding 2mM of Hg(II)in each tube.
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Preparation of NMR solutions for NMR titrations of cAM and Hg(CI04)2
A 142 mM stock solution of cAM (57.3 mg, 0.283 mmol) in DMSO-d6  was 
prepared in a 2 mL volumetric. A 20 mM solution of Hg(C1 0 4 ) 2  (9.07 mg, 0.02 mmol) in 
DMSO-dg was prepared in a 1 mL volumetric. Solutions with metal-to-ligand ratios of
0.156, 0.0208, 0.0313, 0.125, 0.25, 0.50, 1.00, 1.25, 1.50, 2.00 were prepared from the 
stock solutions and DMSO-d6 . To prepare each metal-to-ligand ratio, 65 pL aliquots of 
the 20 mM Hg(C1 0 4 )2 -DMS0 -d6  stock solution were placed in NMR tubes and diluted 
with varying amounts of cAM and DMSO-d6  to obtain total volumes of 650 pL, yielding 
2mM of Hg(II) in each tube.
Preparation of NMR solutions for NMR titrations of cAH and Hg(C104)2
A 17.7 mM stock solution of cAH (7.65 mg, 0.0104 mmol) in DMSO-d6  was 
prepared in a 2 mL volumetric. Separately, a 20 mM stock solution was prepared with 
Hg(C104 ) 2  (9.07 mg, 0 . 0 2  mmol) in DMSO-d6 in a 1 mL volumetric. Solutions with 
metal-to-ligand ratios of 0.125, 0.25, 0.375. 0.50, 0.625, 0.75, 0.825, 1.0, 1.125, 1.25, 
1.375 were prepared from the stock solutions and DMSO-d6 . To prepare each metal-to- 
ligand ratio, 65 pL aliquots of the 20 mM Hg(C1 0 4 )2 -DMS0 -d6  stock solution were 
placed in NMR tubes and diluted with varying amounts of cAH and DMSO-d6 to obtain 
total volumes of 650 pL, yielding 2mM of Hg(II)in each tube.
Preparation of NMR solutions for NMR titrations of cHH and Hg(ClC>4)2
A 17.7 mM stock solution of cHH (9.70 mg, 0.0104 mmol) in DMSO-d6 was 
prepared in a 2 mL volumetric. Separately, a 20 mM stock solution of Hg(C1 0 4 ) 2  (9.07
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mg, 0.02 mmol) in DMSO-d6 was prepared in a 1 mL volumetric. Solutions with metal- 
to-ligand ratios of 0.125, 0.25, 0.375, 0.50, 0.625, 0.75, 0.825, 1.0, 1.125, 1.25, 1.375 
were prepared from the stock solutions and DMSO-d6 . To prepare each metal-to-ligand 
ratio, 65 pL aliquots of the 20 mM Hg(C1 0 4 )2 -DMS0 -d6 stock solution were placed in 
NMR tubes and diluted with varying amounts of cHH and DMSO-d6 to obtain total 
volumes of 650 pL, yielding 2mM of Hg(II) in each tube.
Preparation of NMR solutions for NMR titrations of cHH and Cd(C104)2»H2 0
A 17.7 stock solution of cHH (9.70 mg, 0.0104 mmol) in DMSO-d6 was prepared 
in a 2 mL volumetric. A 20 mM stock solution of cadmium perchlorate hydrate (6.22 
mg, 19.98 mmol) in DMSO-d^ was prepared in a 1 mL volumetric. Solutions with 
metal-to-ligand ratios of 0.125, 0.25, 0.375, 0.50, 0.625, 0.75, 0.875, 1.0, 1.125, 1.25, 
1.50 were prepared from the stock solutions and DMSO-d6 . To prepare each metal-to- 
ligand ratio, 65 pL aliquots of the 20 mM Cd(C1 0 4 )2 «H2 0 -DMS0 -d6  stock solution were 
placed in NMR tubes and diluted with varying amounts of cHH and DMSO-d6 to total 
volumes of 650 pL, yielding 2mM of Cd(II) in each tube.
RESULTS AND DISCUSSION
I. ORGANIC SYNTHESES 
Synthesis of Cyclo(L-Alanyl-L-Histidyl)
The synthesis of cAH was a multistep process. First, it was necessary to 
synthesize the intermediate Z-L-alanine-p-nitrophenol ester by adding 
dicyclohexylcarbodiimide (DCC) and then 4-nitrophenol to a solution of Z-L-alanine 
dissolved in acetonitrile. DCC is a carboxy group activating reagent used widely in 
peptide synthesis. 2 4  The DCC hydrates, forming dicylcohexylurea (DCU), which is 
insoluble in acetonitriole. Since DCU cannot be readily separated from Z-L-alanyl-L- 
histidyl methyl ester (ZAHOMe) by recrystallization, it was necessary to remove it by 
vacuum filtration prior to combining with L-histidine methyl ester.
Triethylamine was added to L-histidine methyl ester dihydrochloride dissolved in 
acetonitrile. The triethylamine neutralized the dihydrochloride salt from L-histidine 
methyl ester because o f the greater basicity of triethylamine over histidine. Removing 
the dihydrochloride from L-histidine methyl ester permited coupling of L-histidine 
methyl ester with Z-L-alanine-p-nitrophenol ester. This coupling reaction produced 
ZAHOMe, the result of amide bond formation between the N terminus of histidine and 
the C terminus of Z-AlaOH. The reaction proceeded because the amide bond is more 
stable than the existing ester bond between the C terminus of Z-AlaOH and the 
nitrophenol group.
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The next step in cAH synthesis involved removing the N-(benzyloxycarbonyl) or 
Z group from the N terminus of alanine. Hydrogenation of ZAHOMe with a palladium 
on carbon catalyst in methanol removed the Z group, yielding AHOMe. AHOMe was 
then refluxed in methanol for approximately 60 hours to facilitate the transesterification 
reaction resulting in cAH. Purification, achieved by recrystallization in methanol, 
yielded 81% cAH (Figure 14).
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Figure 14: Synthesis of Cyclo(L-Alanyl-L-Histidyl)
Synthesis of Cylco(L-Histidyl-L-Histidyl)
Sodium methoxide was used to generate free amines from the commercially 
available dihydrochloride salt of L-histidine methyl ester. The cyclic dipeptide was 
formed from the linear dipeptide produced through an initial intermolecular nucleophilic 
attack of an amine onto the carbonyl of a methyl ester and elimination of methanol.
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Unimolecular cyclization of the dipeptide methyl ester through intramolecular 
nucleophilic attack produced the cyclic dipeptide. Recrystallization from water produced 
cHH in 12.5% yield (Figure 15).
2  N aO CH3
2 HCI HN2
37°C, 8  days
NH
H
H
L-histidine methyl ester dihydrochloride cyclo-(L-histidyl-L-histidyl)
Figure 15: Synthesis of Cyclo(L-Histidyl-L-Histidyl)
The cyclic dipeptide is the major product of this reaction, despite the existence of 
several simultaneous and competing reactions. First, the six-membered ring structure of 
cHH is more stable than any smaller or larger ring structures that could form. Also of 
importance is the close proximity of the carbonyl and amine in the dipeptide, which 
favors internal attack over intermolecular attack. Further, this reaction is 
thermodynamically favored by the greater stability of amides over esters.
Synthesis of Cyclo(L-Alanyl-L-Methionyl)
The synthesis of cAM requires the preparation of several intermediates. 
ZAMOMe, the first of these intermediates, was synthesized via a multistep addition 
reaction. First, triethylamine was added to a solution containing DMF and L-methionine 
methyl ester dihydrochloride to neutralize the dihydrochloride salt. In a separate vessel,
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N-methylmorpholine and isobutyl chloroformate were added to Z-AlaOH to facilitate the 
addition of Z-AlaOH to L-methionine. In this reaction, N-methylmorpholine was added 
to facilitate coupling between Z-AlaOH and isobutyl chloroformate by neutralizing the 
hydrochloric acid formed. The two solutions were then combined within one minute of 
having added isobutyl chloroformate to the Z-AlaOH solution, producing ZAMOMe. 
This coupling reaction was driven by the formation of an amide bond, which is more 
stable than the existing Z-L-alanyl-isobutyl formate ester bond.
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Figure 16: Synthesis of Cyclo(L-Alanyl-L-Methionyl)
The next intermediate in the synthesis of cyclo(L-alanyl-L-methionyl) was 
AMOMe. Hydrogenation of ZAMOMe over a Pd/C catalyst was used to remove the N-
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(benzyloxycarbonyl) group (Z), which was protecting the N terminus of the dipeptide. 
This reaction was favored, as a carbamate bond is subject to reduction much more readily 
than an amide bond. After 24 hours of hydrogenation in a methanol solution, AMOMe 
was produced. To facilitate transesterification, the AMOMe was refluxed in toluene for 
24 hours. Recrystallization from ethyl acetate yielded 7% cAM (Figure 16). Attempts 
to obtain more product from the filtrate were unsuccessful.
Synthesis of Cyclo(L-Leucyl-D-Prolyl)
The synthesis of cLP is very similar to that of cAM. The major difference 
between the two syntheses is the need to couple N(benzyloxycarbonyloxy) succinimide 
to L-leucine in the synthesis of cLP, whereas commercially available Z-L-AlaOH was 
used in the synthesis of cAM. The reason for this additional step is the future interest in 
synthesizing cLP using labeled leucine.
Once Z-LeuOH had been adequately dried, the coupling reaction between Z-L- 
leucine and isobutyl chloroformate was prepared. N-methylmorpholine was added as a 
base to facilitate coupling between Z-L-leucine and isobutyl chloroformate, to form Z-L- 
leucine isobutyl formate. Z-L-leucine isobutyl formate was then combined with L- 
proline methyl ester that was treated with triethylamine to remove the hydrochloride 
group from the amino acid. The resulting major product was ZLPOMe.
ZLPOMe was then hydrogenated with a palladium over carbon catalyst in 
methanol to remove N-(benzyloxycarbonyl), the N terminus protecting group. 
Hydrogenation for 48 hours yielded LPOMe, which was refluxed in toluene. After 24 
hours of refluxing, the toluene solution was reduced via rotary evaporation and the
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resulting solid was recrystallized from tetrachloroethylene, yielding 26% cLP (Figure 
17).
*h 3n  h
Triethylamine, EtOH »
Ultra PureDeionized 
W ater
Z-L-leucine
H3C
N-(benzyloxycarbonyloxy)-succinimide
HN
H3CO
Triethylamine, \  /  CH3
N-methylmorpholine, Isobutyl Chloroform ate 0 H  H3C
THF/DMF
H2 (40 psi), Pd/C, 
MeOH, 48  hrs.
H3C c h 3
Z-L-leucine-D-proline methyl es te r
Reflux in T oluene 
 *
24 hrs.
CX ■ HCI
cyclo(L-leucyl-D-prolyl)
OCH3
D-proline methyl e s te r  hydrochloride
Figure 17: Synthesis of Cyclo(L-Leucyl-D-Prolyl).
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II. MASS SPECTROMETRY ANALYSIS OF CYCLO(L-LEUCYL-D-PROLYL)
J. Poutsma and A. Deer conducted all mass spectrometry experiments using a 
quadrupole ion trap instrument (Finnigan LCQ-Deca™) fitted with an external 
electrospray ionization source. Dilute solutions (ca. 5 x 10' 3 and 5 x 10' 4  M) of the 
cyclic/linear dipeptide in slightly acidified (1% acetic acid) H2 0:CH 3OH (50:50 v/v) 
were directly infused into the mass spectrometer at flow rates in the range of 5-50 
pL/min. A typical mass spectrum of cLP is shown in Appendix 9c. Ions with the mass- 
to-charge ratio of the singly protonated dipeptide were isolated with a typical isolation 
width of 4-5 amu. The mass-selected ions were subjected to collision-induced 
dissociation with the background helium buffer gas serving as the target. Typical 
activation energies were in the range of 10-15 V (peak-to-peak, lab frame) and the 
activation time was 30ps. Product ion scans were then collected using the resonance 
ejection method. The process of ion isolation / fragmentation was repeated to give MS , 
MS4, and MS5 spectra.
Cyclo(L-leucyl-D-prolyl) was isolated and fragmented. The information 
presented in Figure 17 depicts the suspected fragmentation pattern of the cyclic dipeptide.
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III. CYCLO(L-LEUCYL-D-PROLYL) INTEGRATION INTO P 
CYCLODEXTRIN
Integration of cyclo(L-leucyl-D-prolyl) into p cyclodextrin (PCD) was attempted 
by two methods, both based on the procedure outlined by Brett and associates. 2 5  In one 
method (Method I), the cLP and PCD were combined and X-ray quality crystals were 
obtained by slow evaporation of the 1:2 cLP:pCD solution. However, elemental analysis 
of the crystals indicated isolation of pure pCD.
Prior to harvesting the crystals grown in Method I, there was concern pCD water 
inclusion in the crystalline structure of the complex would present a problem, thus 
Method II was proposed. In this method, the same procedure was used to combine cLP 
and PCD, the solution of which was then lyophilized. Using the lyophilization method 
we were able to prepare a powder with reasonable nitrogen content, suggesting the 
presence of cLP. However, the elemental analysis of this sample was not consistent with 
a hydrate of 1:2 cLP'.pCD. These results combined with the elemental analysis 
characterization of the crystals produced in Method I, suggest that cLP is not intercalating 
inside the PCD as desired. This may indicate that the cavity was either too large or too 
small. The cLP may also be interacting with the exterior as opposed to the interior of the 
pCD cavity. Future attempts at cLP integration into a cyclodextrin are warranted, but 
should be attempted with a and y cyclodextrin. These cyclodextrins are larger and 
smaller than pCD, and integration into either one would be adequate for solid-state NMR 
studies.
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IV. NMR SOLUTION-STATE STUDIES OF HG(II) COORDINATION
Solution-State Investigations of Cyclo(L-Methionyl-L-Methionyl)
A series of solutions in which the Hg:cMM ratio was increased from 0 (free 
ligand) to 2:1 with 2 mM Hg(II) were prepared in DMSO-d6 . Proton NMR was 
performed on these solutions at room temperature. Figure 19 depicts the free ligand 
cMM with proton assignments. Figure 20 shows a plot of chemical shift vs. metal-to- 
ligand ratio of hydrogen atoms He, Hd, Hb, Ha, and Hg. Figure 21 shows a stacked plot of 
proton NMR spectra at selected metal-to-ligand ratios.
H3aC-—s
s  ~~CH3a
Figure 19: cMM
The metal-to-ligand ratios 0.0156, 0.0208, 0.0313, 0.0625, 0.125, 0.25, 0.5, 1.0, 
1.25, and 1.50 were selected for to investigate the formation of 1:1 and 1:2 Hg(II):cMM 
complexes. At the [Hg]/[cMM] ratio 0.0313, two small peaks (Hb’ and Hb”)are observed 
at 3.39 ppm and 2.47 ppm. These peaks increase in intensity, but remain at the same 
chemical shift over the course of the study. This suspicious behavior may be explained 
as the two Hb protons becoming prochiral in the presence of Hg(II) and appearing at 
different resonances. This was difficult to assess secondary to the presence of broad
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[Hg]/[cMM] Titration Study
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Figure 20: Chemical shifts of protons He, Hd, Hb, Hb’, Hb ”, Ha, Ha’, and Hg in cMM in
the presence of Hg(C104)2 as a function of metal-to-ligand ratio in DMSO-d6 at room
temperature. Total metal concentration was 2 mM.
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Figure 21: Stack plot of several *H NMR spectra of cMM in the presence of Hg(C104)2
at room temperature in DMSO-cU. Total metal concentration was 2 mM. Metal-to-ligand
ratios = a) 0.0156, b) 0.25, c) 0.50, d) 1.0, e) 1.25.
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water and DMS0-d6 peaks in the same region of the spectrum. A third peak (Ha’) also 
appeared at the 0.0313 ratio. This peak, a singlet, appeared at 1.05 ppm and remained at 
that resonance throughout the rest of the study. It is possible that this peak is the methyl 
peak of a Hg:cHH complex. The noticeable broadening of Ha beginning at the 0.25 
Hg:cMM ratio and then the sudden sharpening of the peak at the 1.0 ratio of Hg:cMM, 
was also of interest. This broadening might be an indication of possible exchange 
occurring between the Ha proton of free ligand and the Ha proton of a mercury complex, 
possibly a 1:2 complex since the change occurs suddenly at the 1.0 ratio. The sharpening 
of Ha may be secondary to the decrease in available free ligand for exchange at the 1.0 
ratio.
These interpretations are speculative, especially since no JH change in chemical 
shift of the protons Hc, Hd, and He was observed. Since the methionyl side chain is 
commonly involved in binding divalent metal ions in vivo, one would expect to observe 
either a change in the chemical shift of the methionyl protons (especially Ha and Hb) or 
observe the appearance of new peaks, representative of some Hg(II):cMM complex. The 
appearance of new peaks Hb’, Hb”, and Ha>, may be suggestive of this Hg(II):cMM 
complex forming. However, while cMM is reported to complex in a 1:2 ratio with Ag(I), 
in vitro, our observations neither support nor refute this. 2 6  Thus the limited availability of 
previous NMR studies and the speculative nature of our observations warrant further 
NMR evaluation of cMM and Hg(II).
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Solution-State Investigations of Cyclo(L-Alanyl-L-Methionyl)
Since the changes observed in the Hg:cMM titration study did not 
definitively suggest the presence of a Hg(II):cMM complex, a repeat titration study that 
substituted cAM for cMM was proposed. The cyclic dipeptide cAM was chosen because 
it has an alanine side chain in place of one of the methionine side chains of cMM, and 
alanine is incapable of metal binding. Thus, it was expected that the methionyl protons 
would exhibit the same changes as observed in the previously discussed Hg:cHH titration 
study, while the alanyl protons would not exhibit any changes over the course of the 
study.
A series of solutions in which the Hg:cAM ratio was increased from 0 (free 
ligand) to 2:1 with 2 mM mercury perchlorate were prepared in DMSO-d6 . Proton NMR 
was performed on these solutions at room temperature. Figure 22 shows a plot of 
chemical shift vs. metal-to-ligand ratio of selected hydrogen atoms. Figure 23 shows a 
stacked plot of proton NMR spectra at selected metal-to-ligand ratios. Figure 24 shows 
cAM with proton assignments.
O
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O
Figure 24: cAM
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[Hg]/[cAM] Titration Study
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Figure 22: Chemical shifts o f protons He, Hh, Hf, Hd, Hb, Hb’, Hb”, Hc, Ha, Ha”, and Hg in
cAM in the presence o f Hg(C104)2 as a function o f  metal-to-ligand ratio in DMSO-de at
room temperature. Total metal concentration was 2 mM,
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Figure 23: Stack plot of several 'H NMR spectra of cAM in the presence of Hg(ClC>4)2
at room temperature in DMSO-d6. Total metal concentration was 2 mM. Metal-to-ligand
ratios = a) 0.0156, b) 0.25, c) 0.50, d) 1.0, e) 1.25.
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The methionyl side chain is commonly involved in binding divalent metal ions in 
vivo and it was expected that the greatest effects of mercury(II) on cAM would be 
demonstrated by a change to the resonances for Ha, Hb, Hc, Hd, and He. As observed in 
the Hg(II):cMM titration study, two peaks appear at the Hg(II):cAM ratio of 0.0313 at 
3.40 ppm and 2.45 ppm. This behavior suggests that the methylene protons (Hb) become 
prochiral in the presence of Hg(II) because the formation of a Hg(II):cAM complex 
changes the effective environment. These peaks increase in intensity but remain at the 
same chemical shift over the course of the study. Also of interest is the appearance of a 
new singlet (Ha>) at 1.05 ppm at the 0.0313 Hg(II):cAM ratio. This peak increases in 
intensity throughout the remainder of the study, while Ha is noticed to decrease in 
intensity throughout the remainder of the study. This intensity change between Ha and 
Ha- suggests the formation of an Hg(II):cAM complex. The broadening of the amide 
peaks at 8.155 ppm (Hh) and 8.182 ppm (He) is also interesting, as it suggests the 
occurrence of exchange, a process that occurs on a time scale comparable to the NMR 
time scale or the frequency difference between nuclear environments. Finally, Ha 
broadened at the ratios 0.25 and 0.5, and then sharpened at ratios above 0.5, only to 
broaden again above 1.0. The change in broadening at the 0.5 ratio of Hg(II):cAM may 
suggest the formation of a 1:2 Hg(II):cAM complex, while the change above 1.0 may be 
suggestive of 1:1 complex formation. These interpretations are merely speculative, as 
concrete evidence for such interactions has not been observed.
The resonances for the alanyl protons, Hf and Hg were nearly unchanged 
throughout the series. The results of this study support the findings of the previously 
discussed Hg(II):cMM titration study in that Hg(II) is suggested to interact with the
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sulfur of methionine. However the exact interaction and complex formation will not be 
fully understood and known without further NMR studies and X-ray analysis.
Solution-State Investigations of Cyclo(L-Hisitdyl-L-Histidyl)
A series of solutions in which the HgicHH ratio was increased from 0 (free 
ligand) to 1.375:1 with 2 mM mercury perchlorate was prepared in DMSO-d6 . Proton 
NMR was preformed on these solutions both at room temperature and at 20°C. Figure 25 
shows a plot of chemical shift vs. metal-to-ligand ratio of selected hydrogen atoms in the 
imidazole region. Figure 26 shows a stacked plot of proton NMR spectra at selected 
metal-to-ligand ratios. Table 1 and 2 show proton chemical shifts of the initial and repeat 
metal-to-ligand titration studies of Hg:cHH.
The histidine side chain is a common binding group for divalent metal cations in 
vivo. cHH (Figure 27) has been shown to form 1:1 and 1:2 metal complexes with Ag (I)
7 7  7 8and Cu (II). ’ Other studies have shown that the 5 nitrogen of the imidazole ring were
7 0bound to Cu(II) in the solid state. Attempts were made to complex cHH with Hg (II), 
but were unsuccessful. Although X-ray quality crystals were not obtained, observed 
NMR data suggests that the 8  nitrogens in the imidazole rings of cHH are primarily 
responsible for metal coordination.
O
;CHb
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0
Figure 27: cHH
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[Hg]/[cHH] Titration Study
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Figure 25: Chemical shifts of  protons Hf, Hb, Ha, He, Hd’, and Hd in cHH in the presence
of Hg(C104)2 as a function of metal-to-ligand ratio in DMSO-d6 at 20°C are shown.
Total metal concentration was 2 mM.
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Figure 26: Stack plot of several lH NMR spectra of cHH in the presence o f Hg(C104)2
at 20°C in DMS0-d6. Total metal concentration was 2 mM. Metal-to-ligand ratios = a)
0.25, b) 0.50, c) 0.75, d) 1.0, and e) 1.25
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The metal-to-ligand ratios of 0.125, 0.25, 0.375, 0.50, 0.625, 0.75, 0.875, 1.0, 
1.125, 1.250, and 1.375 were selected to investigate formation of 1:1 and 1:2 complexes. 
Free cHH was observed to have three relatively sharp peaks between 8.0 and 6.7 ppm. 
Two of these peaks (Ha and Hb) correspond to the C-H hydrogens on the imidazole ring. 
The other is the amide proton (Hf) found on the nitrogen next to Ca in the cHH ring. 
This proton shifted the most downfield, moving 1.004 ppm over the course of the study, 
suggesting the occurrence of changes in the ring structure, like folding.
Each of the C-H imidazole proton resonances (Hb, Ha) were observed to shift 
significantly downfield (0.746 and 0.572 ppm respective total chemical shifts) over the 
course of the study. These peaks also broadened significantly compared to those 
observed in the ]H NMR of free ligand. This is suggestive of an exchange process 
occurring on a time scale comparable to the NMR time scale or the frequency difference 
between nuclear environments. Hc was not observed at all in this study. This was 
expected since proton NMRs of cHH spiked with D2 O and MeOD show this proton is 
highly exchangeable with both solvents. All of these observations suggest the primary 
Hg(II) and cHH interaction occurs with the 6  nitrogen, as the proton Hb experiences the 
most signifcant downfield shift (0.746 ppm) of the two C-H imidazole protons as the 
Hg:cHH ratio is increased. Also indicative of Hg(II) interaction with the imidazole ring 
is the shift observed in proton Hd. This proton shifts closer to Hd* from the ratio 0.25 to
1.0 and then appears to move upfield above the 1.0 Hg(II):cHH ratio. This would suggest 
two things, the first being Hg(II) interaction with the imidazole ring that changes the 
environment of the Hd and Hd> (methylene) protons by stopping Ca—Cp bond rotation. 
Also, since the upfield shift in Hd’ resonance stops at the. 1.0 ratio, the formation of a 1:1
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Hg(II):cHH complex is suggested. The formation of a 1:2 Hg(II):cHH complex may be 
suggested by the change in the slope of the Hd proton chemical shift plotted in Figure 25. 
X-ray analysis and further studies will elucidate the exact complex formed.
Overall, this data was highly reproducible. In only one case (proton H f at 0.375 
[Hg]/[cHH]) was the data difference greater than 0.094 ppm. The change observed in 
chemical shifts of the methylene protons of cHH was similar to the change observed in 
the chemical shift of the methylene protons of cMM. This similarity between the two 
studies may further support Hg(II) interaction with the sulfur on the methionyl side chain.
Solution-State Investigations of Cyclo(L-Alanyl-L-Histidyl)
Since alanine is a non-metal binding side chain, cAH was studied with the hopes 
that titration studies of the dipeptide with Hg(II) would provide better insight into 
understanding the Hg(II)-histidine interactions observed in the Hg(II):cHH study. A 
series of solutions in which the Hg:cAH ratio was increased from 0 (free ligand) to 1.375 
with 2 mM mercury perchlorate was prepared in DMSO-d6 . Proton NMR was preformed 
on these solutions at 20°C. Figure 28 shows a plot of chemical shift vs. metal-to-ligand 
ratio of selected hydrogen atoms. Figure 29 shows a stacked plot of proton NMR spectra 
at selected metal-to-ligand ratios.
Free cAH (Figure 30) was observed to have four sharp peaks (Hf, Hj, Hb, and Ha) 
between 6 . 8  and 8.2 ppm. Each of these peaks were observed to broaden in the presence 
of Hg(II). This broadening is suggestive of the occurrence of an exchange process. Also 
of interest was the upfield shift of the amide proton H f and the C-H imidazole protons Hb 
and Ha by 0.904, 0.546, and 0.586 ppm, respectively, between free ligand and the 1.375
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Hg:cAH Titration Study
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Figure 28: Chemical shifts o f protons Hf, Hj, Hb, Ha, He, Hh, Hd, and Hg in cAH in the 
presence o f Hg(C104)2 as a function of metal-to-ligand ratio in DMSO-d6 at 20 °C. Total 
metal concentration was 2 mM. Histidine protons are represented by solid shapes, while 
alanine protons are represented by open shapes.
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Figure 29: Stack plot of several !H NMR spectra of cAH in the presence of Hg(C104)2
at 20°C in DMSO-d6- Total metal concentration was 2 mM. Metal-to-ligand ratios = a)
0.25, b) 0.50, c) 0.75, d) 1.0, and e) 1.25
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Hg(II):cAH ratio. A change in the Hb and Ha proton environments suggested by the 
change in the chemical shift of these protons may also indicate the formation of a Hg(II)- 
cAH complex. Hb shifts the greatest over the course of the study, which supports the 
interaction of mercury (II) with the 5 nitrogen on the imidazole ring. Since Hb is the 
closest proton of the imidazole ring to the proposed mercury interaction site, one would 
expect to note the greatest change the chemical shift of this proton. Another point of 
interest is the upfield shift of Hf, which suggests a change in the cAH ring environment 
consistent with the formation of a Hg(II)-cAH complex. The change in the slope of the 
protons Hf, Ha, and Hb (plotted in Figure 27) seems to level off at ratios of Hg(II):cAH 
above 0.5. This may suggest the possible formation of a 1:2 Hg(II):cAH complex. Also, 
the change observed in Hd between 0.25 and 0.5 from a singlet to an overlapping doublet 
of doublets indicates a change in the stereochemistry of the methylene protons, which 
may support this possibility of 1:2 complex formation. The doublet of doublets reverts 
to a singlet at ratios above 0.625, which is why only two Hd’ points (represented by an x) 
are plotted in Figure 28. Hd also broadens in the presence of Hg(II), suggesting the 
occurrence of an exchange process, which further suggests the formation of a Hg(II):cAH
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complex. This interpretation of results is only cursory, requiring further NMR and X-ray 
analysis studies for confirmation.
The alanyl protons Hg, Hh, and Hi remained nearly unchanged throughout the 
study, shifting at total of 0.166 ppm, 0.094 ppm, and 0.311 ppm, respectively, over the 
course of the study. This indicates that the environment of the alanyl protons changes 
minimally over the course of the study. Therefore, the association between mercury (II) 
and cAH most likely occurs on the histidyl side chain since the greatest change in 
chemical shift is observed with the histidyl protons, which supports the observations and 
analysis of the Hg(II):cHH titration study.
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IV. NMR SOLUTION-STATE STUDIES OF CADMIUM(II) COORDINATION
Solution-State Investigations of Cyclo(L-Histidyl-L-Histidyl)
A series of solutions in which the Cd:cHH ratio was increased from 0 (free 
ligand) to 3:2 with 2 mM cadmium perchlorate was prepared in DMSO-d6 . Proton NMR 
was performed on these solutions at room temperataure. Figure 31 shows a plot of 
chemical shift vs. metal-to-ligand ratio of selected hydrogen atoms. Figure 32 shows a 
stacked plot of proton NMR spectra at selected metal-to-ligand ratios.
In general, peak broadening, suggestive of exchange processes occurring, is 
apparent in all cadmium containing samples, when compared to the ]H NMR spectra of 
free cHH (Appendix 5). The presence of free ligand is apparent throughout the study, as 
indicated by constant slope of the solid shapes in Figure 31. The intensity of the free 
ligand peaks noticeably decreases over the course of the study, suggesting a decrease in 
overall free ligand. Additional peaks at 8.19, 7.43, 6.04, and 4.31 ppm arise at the 0.375 
and 0.50 ratios of Cd’.cHH and increase in intensity over the course of the study 
suggesting that a Cd:cHH complex is forming. Since two sets of cHH resonances were 
not observed in identical HgicHH studies, cadmium may exchange more slowly than 
mercury under these study conditions. Analysis o f the behavior of the Hd and Hd’ protons 
was complicated by potential overlap with the broad water and DMSO-d6  resonances. 
However, it appears the peaks of Hd and Hd- migrate to overlap at 2.83 ppm. The overlap 
of the two protons begins at the 1.0 ratio of Cd(II):cHH and continues throughout the rest 
of the study. This trend suggests the formation of a 1:2 Cd(II):cHH complex.
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Figure 31: Chemical shifts of protons Hf, Hb, Ha, He, and Hd in cHH in the presence of
Cd(C104)2*H2 0  as a function of metal-to-ligand ratio in DMSO-d6 at room temperature.
Total metal concentration was 2 mM.
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Figure 32: Stack plot of several *H NMR spectra of cHH in the presence of
Cd(C104)2-H2 0  at 20°C in DMS0-d6. Total metal concentration was 2 mM. Metal-to-
ligand ratios = a) 0.25, b) 0.50, c) 0.75, and d) 1.0
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Recent studies have shown that both cadmium (II) and mercury (II) can be 
substituted for and readily adopt the coordination environment of native metal ions . 1 0 , 3 0 ' 3 4  
Comparable binding of Cd(II) and Hg(II) to small ligands has also been observed . 3 5  ]H 
NMR studies with small, non-oxygen containing ligands have suggested that the solution 
equilibria of the Cd(II) and Hg(II) systems were comparable as the proton chemical shifts 
with various mole ratios of Cd(II) were only shifted slightly downfield in comparison to 
identical ratios of Hg(II) . 3 5  In the Cd:cHH titration study, the ligand-metal complex 
proton shifts are significantly different from the trend observed in the Hg:cHH study.
In general, cHH proton chemical shifts increase in the presence of Hg(II), whereas 
in the cadmium study no general trend of proton shifting can be assessed. The Cd(II) 
complex related protons He’ and Hf shift slightly downfield from free ligand (0.3 and 0.2 
ppm, respectively), while Hb> shifted slightly upfield (0.2 ppm) and Ha> shifted 
significantly upfield (0.8 ppm). This appreciable difference in trends between cadmium 
and mercury titration studies may be attributable to the presence of oxygen in the cHH 
ligand used. This is supported by previous indications that cadmium (II) and mercury 
(II), while in the same periodic family, possess complementary coordination
35 •preferences. Cadmium preferentially binds to hard ligands like oxygen, while softer 
ligands, like sulfur, are preferred by mercury . 3 5  Since cadmium is more oxophilic, there 
is a possibility of different binding modes with oxygen containing ligands, which may 
explain the difference between the observed Hg(II) and Cd(II) complexing trends with 
cHH.
CONCLUSION
The syntheses of cyclo-(L-alanyl-L-methionyl) was completed by using a strategy 
that employed protecting the nitrogen terminus with N-benzyloxycarbonyloxy and 
protecting the carboxy terminus with a methyl ester to prevent multimerization and 
racemerization. The syntheses of cyclo-(L-alanyl-L-histidyl) and cyclo(L-leucyl-L- 
prolyl) were completed using similar strategies. Integration of cLP into pCD was 
unsuccessful because cLP did not associated with pCD as predicted. This may be a result 
of the PCD cavity being either too small or too large. Future studies should be aimed at 
attempting cLP integration into either a or yCD, which have different cavity sizes.
The analysis of cMM NMR titration data in DMSO-d6 proved to be more difficult 
than expected. The coordination of Hg(II) and methionyl is remotely suggested by both 
the cMM and cAM titration studies, which also indicate the possibility of 1:2 and 1:1 
complex formation. However, further evaluation of these interactions is needed to 
substantiate these rudimentary conclusions.
The histidyl side chain, specifically the 5 nitrogen of the imidazole ring, was 
tentatively established as the primary site for Hg(II) interaction in cAH and cHH. 
Analysis indicates that there is an intermediate exchange rate in the equilibrium that is 
too slow on the NMR time scale for a sharp, time averaged signal. In the presence of 
mercury, there is evidence that the exchange rate is too fast for individual species 
detection. Analysis of the Cd(II) titration study provides some evidence that the
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exchange process in the presence of cadmium is slower than that observed in the mercury 
study, as multiple species peaks are distinct. These conclusions are however merely 
speculative, as X-ray analysis of solid crystals corresponding to these complexes has not 
been achieved.
The low solubility of cHH and its complexes in solution has proven the greatest 
problem in growing the crystals needed for X-ray analysis. While solvents have been 
discovered to solvate Hg(II):cHH complexes, they possess high boiling points and are not 
favorable for slow evaporation crystal growing. Alternate strategies, like cosolvent 
layering, have not been successful at this time, as a cosolvent that is miscible with DMSO 
in all proportions that does not solvate cHH or its complexes has not been identified.
Immediate future plans include synthesis and X-ray analysis of Hg:cHH crystals 
obtained in 1:1 and 1:2metal-to-ligand ratios, as well as X-ray analysis of a  or y 
cyclodextrin integrated cLP crystals made in 1:2 ratio of guest to host. Pending are solid- 
state NMR analyses of labeled and unlabeled cLP as a free ligand and as a guest in either 
a  or y cyclodextrin in 1:2 guest to host ratio. Also incomplete at this time are mass 
spectrometry studies on cLP, LPOMe, PLOMe and PPOMe. Overall, this study was 
designed to provide a library of characterizations of the synthesized dipeptides to be 
compared with results of the eventual investigation of the potential of 199Hg NMR to 
structurally characterize metalloproteins. Future research in this laboratory is aimed at 
exploring the utility of mercury NMR in the characterization of structural features of 
protein metal coordination sites.
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Appendix 1: !H NMR of 166 mM ZAHOMe in DMS0-d6 at 20°C.
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Appendix 2: (a) *H NMR of 235 mM cAH in DMSO-d6 at 20°C. (b) 13C N M R of235
mM cAH in DMSO-d6 at 20°C.
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Appendix 3: (a) 'H  NMR of 6 8  mM cHH in DMSO-d6  at 100°C. (b) 1 3C N M R o f 6 8  
mM cHH in DMSO-cU at 20°C.
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Appendix 4: NMR of ZAMOMe at room temperature in DMSO-d6 . Concentration
unknown.
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Appendix 5: (a) NMR of 118 mM cAM in DMSO-d6 at 100°C. (b) 13C NMR of 118
mM cAM in DMS0-d6 at 20°C.
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Appendix 6 : *H NMR of ZPLOMe in DMSO-d6 at 20°C. Concentration unknown 
secondary to ZPLOMe being an oil.
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Appendix 7: !H NMR of Z-LeuOH in DMSO-d6  at 20°C. Concentration of sample 
unknown secondary to Z-LeuOH being an oil.
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Appendix 8 : NMR of ZLPOMe in DMSO-d6  at 20°C. Concentration of sample
unknown secondary to ZLPOMe being an oil.
Appendix 9: (a) ‘H NMR of 140 mM cLP in DMSO-d6 at 20°C. (b) 13C NMR of 140
mM cLP in DMSO-d6 at 20°C.
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endix 9: c) Mass Spectrometry of cLP in H2 O.CH3 OH (50:50 v/v).
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Appendix 10: (a) ‘H NMR of 141 mM cPL in DM S0-d 6  at 20°C. (b) 13C NMR of 141 
mM cPL in DMSO-d6  at 20°C.
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Appendix 11: 'H  NMR of 55 mM cMM in DMS0-d6 at 20°C.
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